What is Affimed NV (AFMD) stock price today?

Affimed NV (AFMD) currently trades at $0.18 per share. The stock has a market capitalization of $2.98M and a P/E ratio of —x.

Is AFMD stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Affimed NV has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Affimed NV's revenue and earnings?

Affimed NV has trailing twelve-month (TTM) revenue of $5.64M with profit margins of 0.00%. Earnings per share (EPS) is $-5.09.

AFMD

Affimed NV

NASDAQ: AFMD · HEALTHCARE · BIOTECHNOLOGY

$0.18

+0.00% today

Updated 2026-04-29

Market cap

$2.98M

P/E ratio

—

P/S ratio

0.53x

EPS (TTM)

$-5.09

Dividend yield

—

52W range

$0 – $1

Volume

23.5M

Market cap

$2.98M

P/E ratio

—

P/S ratio

0.53x

EPS (TTM)

$-5.09

Dividend yield

—

52W range

$0 – $1

Volume

23.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$0.40

+122.04%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-11.14M

- Revenue declining -91.60% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2020	2021	2022	2023	TTM
Revenue	$28.36M	$40.37M	$41.35M	$8.28M	$5.64M
Net income	$-41.37M	$-57.52M	$-86.00M	$-105.94M	$-15.14M
EPS	—	—	—	—	$-5.09
Free cash flow	$-19.84M	$-90.44M	$-105.59M	$-114.00M	$-11.14M
Profit margin	-145.86%	-142.50%	-207.98%	-1,280.22%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AFMD	$2.98M	34	2.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Affimed NV trades at $0.18. Our Smart Value Score of 34/100 indicates the stock is weak. TTM revenue stands at $5.64M.

Frequently asked questions

What is Affimed NV's stock price?

Affimed NV (AFMD) trades at $0.18.

Is Affimed NV overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell).

What is the price target of Affimed NV (AFMD)?

The analyst target price is $0.40, representing +122.0% upside from the current price of $0.18.

What is Affimed NV's revenue?

TTM revenue is $5.64M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.53x

ROE-149.50%

Beta2.07

50D MA$0.50

200D MA$1.76

Shares out0.02B

Float0.02B

Short ratio—

Avg volume23.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

AFMD vs LLY →AFMD vs JNJ →AFMD vs ABBV →Stock screener →